FIDSX | FSPCX | FIDSX / FSPCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 43 years | 39 years | - |
Gain YTD | 4.695 | 2.562 | 183% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.08B | 930M | 116% |
Annual Yield % from dividends | 1.86 | 0.89 | 208% |
Returns for 1 year | 28.29 | 9.61 | 294% |
Returns for 3 years | 24.26 | 37.15 | 65% |
Returns for 5 years | 57.69 | 46.20 | 125% |
Returns for 10 years | 93.38 | 45.85 | 204% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BGLD | 20.10 | 0.18 | +0.90% |
FT Vest Gold Strategy Qt Buffer ETF | |||
APRW | 33.46 | -0.17 | -0.51% |
AllianzIM US Large Cap Buffer20 Apr ETF | |||
EWU | 36.36 | -0.19 | -0.52% |
iShares MSCI United Kingdom ETF | |||
BBC | 21.75 | -0.40 | -1.80% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
RSPG | 81.51 | -2.23 | -2.66% |
Invesco S&P 500® Equal Weight Energy ETF |